Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the drug-drug interaction in your body when given the
study drug, bexagliflozin, with three commonly used ant-diabetic medications, metformin,
glimepiride or sitagliptin. The study will also evaluate how safe the study drug is and how
well the study drug is tolerated when taken with metformin, glimepiride or sitagliptin.